Independent Director Ameetkumar Desai Completes First Term

Management Changes View source PDF Explain this filing

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.3%Reaction day

₹2041.00

prior close

₹2088.60

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+5.6% vs market

Pharmaceuticals peers, median of 173sector+2.0%+5.3% vs sector

On the reaction day the stock moved 5.6 pts more than Nifty Microcap 250 and 5.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.1

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.3+1.7+5.6+2.0+5.3

Next day

+9.4pendingpending+2.6+6.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ameetkumar Desai's first term as an independent director ended at the close of business on 27 October 2026. He informed the company that he will not seek a second consecutive term and consequently ceased to be an independent director. The company thanked him for his contribution.

Likely market impact

Independent board representation has fallen by one until a replacement is appointed. The filing does not indicate any governance dispute.